Proposal of a classification of cannulation damage in vascular access grafts based on clinical, ultrasound, and microscopic observations.

Cannulation damage alone does not solely account for AVG failure. It results from a biological host-mediated process that promotes the growth of intimal hyperplasia at the cannulation sites. This process is not clinically significant within the initial 2 years after AVG creation.